Orchid Pharma Inks USD 80 Million Latin American Licensing Deal for Exblifep
Orchid Pharma enters a licensing deal with Laboratorio Libra for Exblifep in Latin America, representing a potential USD 80 million opportunity over 10 years.
ALFA News
Straight from the exchange filing
Every announcement Orchid Pharma has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Orchid Pharma announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Orchid Pharma enters a licensing deal with Laboratorio Libra for Exblifep in Latin America, representing a potential USD 80 million opportunity over 10 years.
Orchid Pharma Ltd's board has approved an enabling resolution to raise up to ₹600 crore through equity or debt, representing 11.2% of its current market cap.
Track Orchid Pharma in real time
ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Orchid Pharma files something material.